key: cord-0978202-ke0hrhog authors: Cardenas, Nicky C title: COVID-19 emergency vaccine task force: enhancing EU and US strategic interconnectivity approach on inter-regional blocs’ vaccination programs date: 2021-09-25 journal: J Public Health (Oxf) DOI: 10.1093/pubmed/fdab293 sha: 39d7426ac3e3d5b17c5ab7fbc28f8893087a280f doc_id: 978202 cord_uid: ke0hrhog nan In a recent editorial published in this 'Journal of Public Health' (Oxford), editors Professor Premila Webster and Professor Keith Neal critically pointed out that an inclusive approach on strategies and policies for COVID-19 and future pandemics is direly needed to address glaring gap between rich and poor countries. The editorial rightfully emphasized that, 'there needs to be a global recognition of long-standing social inequities related to race, disability, class, caste and gender'. 1 With this, global COVID-19 vaccine strategic policies must leverage an efficient and holistic approach to end COVID-19 and future pandemics. However, evidence revealed continuous challenging gaps in the global COVID-19 vaccine equity. Thus, this study critically proposes to European Union (EU) and USA to step up strategic policy beyond borders toward a more concrete, comprehensive and coordinated 'interconnectivity approach' on COVID-19 vaccine roll-out among G7, G20, Mercosur, Pacific Alliance (PA), African Union (AU) and Association of Southeast Asian Nations (ASEAN) blocs to aid COVID-19 hard-hit poor countries. This paper urges EU-US governments to enhance 'joint COVID-19 emergency vaccine task force' with key interregional blocs to address the glaring gaps on global COVID-19 vaccine equity between rich and poor countries throughout the world. In recent correspondences, evidence revealed fostering inclusive strategic policies to address the urgent need for global COVID-19 vaccine equity through US-European centrality, 2 US-European and ASEAN multilateral diplomacy, 3 ASEAN centrality for COVID-19 relief responses, 4 and significant acceleration for development and manufacture of COVID-19 vaccines through crucial role of 'COVAX facility, World Health Organization (WHO) and United Nations Children's Fund (UNICEF)'. 5 However, despite the recent evidence concerning global strategic policies and notable recent inter-governmental efforts to address gaps on global COVID-19 vaccine strategy, efficient prompt action is direly needed to address gaps concerning EU-US strategy on 'Infodemic', 6 EU-US and AU inter-regional COVID-19 cohesive strategic policy 7 and EU, US, Latin America and the Caribbean coordinated multilateral strategic policy. 8 These revealed critical underlying complex issues on COVID-19 vaccine hesitancy, supplies and production issues which must be addressed simultaneously. With the current threats posed by Delta variant, there is indeed a long way to go to achieve sustainable COVID-19 global recovery. Recently, United Nations (UN) emphasized that evidence showed 'two-track pandemic' due to the global COVID-19 vaccine failure, which paved the way for COVID-19 to mutate rapidly. 9 UN also urged the European Parliament to address gaps on global vaccine inequities to leverage 'emergency COVID-19 vaccine task force'. 10 But despite UN efforts to scale up COVID-19 vaccine roll-out and manufacturing production, critics raised an issue on COVAX-WHO being grossly behind on attaining its goal to provide 2 billion doses by the end of 2021 due to 'business as usual approach' involving pharmaceutical companies. 11 Remarkably, COVAX-WHO has so far shipped 89 million COVID-19 vaccines to 133 countries with the goal to scale up delivering 1.8 billion doses to lower-income economies in the first quarter of 2022. 12 This implies that COVAX-WHO is doing its best to reach out to poor countries, but there is a need to rethink and address loopholes on its strategic model to achieve its main goal to end COVID-19 and prevent future pandemics. Henceforth, this paper urges GAVI-WHO and EU-US centrality to step up joint strategic partnerships, including but not limited to G7, G20, Mercosur, PA, AU and ASEAN blocs toward an enhanced 'joint emergency COVID-19 vaccine task force', to include more specific innovative 'mRNA vaccine technology transfer hub' across the world and to address the issue on 'business as usual approach' encompassing COVID-19 vaccines procurement, roll-out and manufacturing production between the rich and poor countries during pandemics. Normal led to this" -where next? US-European centrality': strategic policy for global COVID-19 response and health security US-European and ASEAN strategic plan on COVID-19: a proposed multilateral diplomacy Strengthening ASEAN centrality on COVID-19 relief: a joint multilateral strategic policy We will only be safe when everybody is safe! Europe and United States vaccine hesitancy': leveraging strategic policy for 'Infodemic' on COVID-19 vaccines European Union-United States and African Union inter-regional COVID-19 response: fostering a cohesive strategic policy on vaccine hesitancy COVID-19 vaccine strategy: promoting a coordinated multilateral strategic policy among European Union, United States, Latin America and the Caribbean COVID-19 Delta Variant Has Potential to Make 'Epidemic Curve Exponentially UN Chief Urges European Parliament to Support COVID Vaccines for All Ahead of Gavi's Board Meeting, MSF Urges Critical Look at COVAX Shortcoming COVAX Vaccine Roll-Out No funding was received in this paper. The author declares no conflict of interest in this paper.